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Transcutaneous electrical nerve stimulation (TENS) has been shown to be an effective measure for pain
relief. Theaimofthe present studywas todeterminethe optimal intensityandintervalof repeated 100Hz
TENS for the treatment of chronic inflammatory hyperalgesia in a monoarthritic pain model of the rat,
and to assess the changes of the spinal substance P (SP) release in response to TENS treatment. A
reliable, reproducible chronic monoarthritic pain model was produced by intra-articular injection of
complete Freund’s adjuvant (CFA) at single ankle joint. The efficacy of 100 Hz TENS treatments with
different frequencies and intensities was compared. In the acute period (within 3 weeks) of
monoarthritis, twice-a-week schedule of TENS reduced the swelling of the inflamed ankle significantly.
In the stable period (4–9 weeks), however, once-a-week schedule produced a significantly better
therapeutic effect on both inflammation and arthritic hyperalgesia than that of twice- or five-times-a-
week schedule. Using three levels of intensity of TENS, we found that the weaker (1-1-2 mA)
stimulation produced significantly better therapeutic effects. Repeated TENS produced a reduction of SP
content in spinal perfusate in parallel with the progressive reduction of the arthritic pain scores. Our
results suggest that (i) consecutive TENS treatments produced cumulative effect for chronic
hyperalgesia, (ii) for chronic inflammatory hyperalgesia, a weaker intensity and more sparsely arranged
treatment schedule may produce better therapeutic effect and (iii) a decrease in SP release may serve as
one of the possible neurochemical mechanisms underlying the therapeutic effects of multiple TENS
treatments on chronic inflammatory hyperalgesia.
Keywords: chronic inflammatory hyperalgesia – Freund’s adjuvant – monoarthritis – substance P –
transcutaneous electrical nerve stimulation (TENS)
Introduction
Pain is one of the most serious medical problems encountered
today. Chronic pain, characterized by its long duration, slow
recovery and difficulty to control in clinical practice, makes it
even more serious than acute pain both physically and
psychologically. It is thus an imperative and formidable task
for researchers to demonstrate the mechanisms of chronic pain
and find effective therapy for its treatment. Transcutaneous
electrical nerve stimulation (TENS), which has been
developed in the past 30 years, is now being used more and
more extensively for pain relief (1).
Early studies of TENS-induced analgesia mainly focused on
the immediate effect induced by single treatment (1). It has
been demonstrated that frequency, intensity, electrode place-
ment and pulse duration are the important impact factors on
the TENS effect (2–4). However, clinical data indicate that
repeated electrical stimulation could produce cumulative
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acute tests may not be applicable in cases with chronic pain. It
has drawn more and more attention to find the suitable
parameters for the therapeutic efficacy of multiple TENS
treatments (7–9). Among many factors, the less well-
characterized parameter is the time interval between two
consecutive sessions of TENS, which played an important role
in the outcome of long-term effect in normal rats (W. Xu, PhD
thesis, Department of Physiology, Beijing Medical University,
Beijing, China, 1995). In the present study, we characterized
the optimal interval and intensity of repeated 100 Hz TENS for
the treatment of chronic hyperalgesia induced by injecting a
small amount of water-in-oil type complete Freund’s adjuvant
(CFA) into single ankle joint in rats.
A great deal of evidence indicates that substance P (SP)
as a neurotransmitter or neuromodulator is involved in the
transmission of nociceptive signals in the spinal cord (10,11).
It has been shown that SP release in spinal cord and peripheral
tissue was increased during the development of inflammation
(12,13) and that TENS or acupuncture might alter the noxious
nerve stimulation-induced release (14,15) and production (16)
of SP in the spinal cord, which may be frequency dependent
(17). Whether spinalSPrelease wasalteredby repeated 100 Hz
TENS was also characterized in the present study.
Methods
Rats
Wistar female rats obtained from the Experimental Animal
Research Center, Peking University, were used throughout
the study. They arrived at a weight of 150–200 g, were housed
4–6 rats per cage with sawdust bedding and given food and
water ad libitum. Experiments were conducted according to
the Ethical Guidelines for Investigation of Experimental Pain
in Conscious Animals (18) and were approved by the local
ethics committee for animal research of Peking University.
Indices obtained in the present study were observed and
measured by one of the authors (H.-X. L.) throughout the
experiments to avoid interobserver differences.
Induction of Monoarthritis
Preparation of Water-in-Oil Type CFA
Two 1 ml syringes were used, one filled with incomplete
Freund’s adjuvant (IFA) (0.85 ml paraffin oil mixed with
0.15 ml Aracel A in 1 ml, Gibco Company), and another with
equal volume of suspension of killed Mycobacterium tuber-
culosis (Human strain, 20 mg ml
 1, Chinese Inspection
Institute for Biological Materials, Beijing). They were inter-
connected with each other through a plastic catheter of  6c m
long. Careful attention was paid to avoid air bubbles in the
catheter and syringes. The pistons of the two syringes were
pushed alternately until thick water-in-oil emulsion was
formed. The preparation of the control IFA was the same as
that for CFA with the exception that the suspension of killed
M. tuberculosis was substituted with normal saline.
Intra-articular Injection
Intra-articular injection to the tibio–tarsal joint was performed
as described by Butler et al. (19). Briefly, rats were
anesthetized with 10% chlorohydrate (300 mg kg
 1, i.p.).
Freund’s adjuvant (30 ml) was injected into the right ankle joint
through a 26
1/2-gauge needle inserted into the articular cavity.
Transcutaneous Electrical Nerve Stimulation
The monoarthritic rats were restrained in a specially designed
holder with the hind legs and tail exposed. The hair on the
lower legs was removed with saturated barium sulfide (BaS)
solution and rinsed thoroughly with water. After wiping and
drying the legs, two pairs of round platinum electrodes (5 mm
diameter) were attached tightly on both legs, one on the normal
saline wetted skin of Zusanli (ST36, the lateral side of the
anterior tibial tubercle of the leg at the level between upper
one-third and lower two-third of the tibia) and another on the
medial side at the same level to form a circuitry. The Eight
channel HANS stimulator used was manufactured by the
Beijing Medical University. The parameters for TENS output
were as follows: 0.2 ms pulse width, 100 Hz frequency and
30 min duration per session. The intensity of stimulation was
arranged at three levels as follows: weak (1-1-2 mA), medium
(1-2-3 mA) or high (2-3-4 mA), with current increasing
stepwise, each step lasting for 10 min. For mock stimulation,
the skin electrodes were placed on the same regions but no
current was delivered. To find the optimal interval of TENS
treatment, once-a-week, twice-a-week or five-times-a-week
schedule was used with the medium intensity stimulation.
Indices for Behavioral Observations
Behavioral observations included body weight, circumfer-
ences of the ankle joints bilaterally, leg-withdrawal threshold
and scores of arthritic flexion (both plantar and dorsal flexion)
pain test. The rats were weighed before putting in the holder.
The other measurements were made 30 min after the rats were
restrained. These measurements were taken once-a-week
before TENS treatment with the observation time allocated
in the morning between 8:00 a.m. and 12:00 noontime.
Measurement of Ankle Circumference
The circumferences of the ankles were measured around the
lower edge of lateral and medial malleolus with a flexible ruler
without elasticity.
Measurement of Leg-withdrawal Threshold
Randall–Selitto response was determined with continuously
increasing pressure applied on one side of the ankle joint. The
value of pressure (mm Hg) was recorded at the withdrawal of
the leg. The mean value of two measurements with a 30 min
66 TENS suppresses inflammatory pain and SP releaseinterval was taken as the final result of the paw withdrawal
threshold. The threshold of the contralateral side was
examined 15 min later.
Scoring of Arthritic Flexion Pain Test
The ankle joint was gently flexed to the plantar direction for
5 times with an interval of 5 s. The same manipulation was
used and the force onto the ankle was monitored by the color
change of the thumb fingertip induced by blockade of blood
circulation. The leg-withdrawal scores were measured, respec-
tively. It was scored zero when rats showed no quick leg-
withdrawal; scored 1 when the brisk withdrawal reaction
appeared. A total leg-withdrawal score was obtained between
0 and 5 for each test session. The same scoring method was
employed for dorsal flexion test, which was proceeded to the
extent that the toes touched the front of the leg.
X-ray Examinations
Radiographic evaluation (40 kV, 2 ms) was performed under
light anesthesia based on whole body radiographs and coned-
down views of the hind limbs.
Radioimmunoassay of SP
Rats were anesthetized with chlorohydrate. A PE-10 catheter
was inserted into the subarachnoid space through the cisterna
magna with the tip reaching the level of lumbar spinal
enlargement. Another piece of polyethylene tube (PE-50)
was inserted 10 mm down the cisterna. Artificial cerebrospinal
fluid contained bacitracin (30 mg l
 1), a peptidase inhibitor,
was perfused at a rate of 1.0 ml per 30 min with a push–pull
pump (20). The spinal perfusate (1.0 ml) was collected in the
Eppendorf vials immersed in an ice-water bath and then heated
for 10 min in boiling water bath. After cooling down to room
temperature, the perfusate was centrifuged at 10000 g for
10 min. Supernatants were lyophilized and stored at  20 C.
The lyophilized perfusate was reconstituted in 250 mlH 2O
for the radioimmunoassay (RIA) of SP.
125I-SP RIA kits were
bought from the Basic Research Institute, Chinese Academy of
Medical Sciences, Beijing. The SP antiserum showed no
detectable cross-reactivity with ACTH, angiotensin II and
Met-enkephalin, <0.01% with eledoisin, <0.008% with
eledoisin-related peptides. The non-specific binding rate was
6.18%, total binding 35.8% and IC50 112 fmol per tube.
Standards (or samples) (100 ml), SP antiserum (1:6500, 100 ml)
and [
125I]SP (10000 dpm, 100 ml) were added to the
polyethylene test tubes, mixed thoroughly and then incubated
for 72 h at 4 C. For the separation of bound from free peptide,
1 ml 0.5% Dextran-T70-wrapped active carbon was added into
the above assay system while mixed in an ice-water bath. The
mixtures were centrifuged for 20 min at 1750 g, 4 C following
10 min of standstill on bench. The supernatants were counted
using micro-g-counter.
Data Processing and Statistical Analyses
The results were presented as mean ± SEM for continuous data
(body weight, ankle circumference, withdrawal threshold of
pressure to ankle, content of SP-ir) or as median ± median-
derived absolute deviation (MAD) for the non-parametric data
(pain scores). Continuous data were processed with two-way
analysis of variance (ANOVA) followed by Duncan’s test. For
the discrete data (pain scores), Friedman ANOVA (repeated
measures ANOVA on ranks) was used to analyze the change of
pain scores with the time course within the group, Kruskal–
Wallis ANOVA (one-way ANOVA on ranks) followed by
Dunn’s test or Mann–Whitney U-test for the comparison
between the groups at the same time point. A P-value of <0.05
was considered statistically significant.
Results
Assessment of Monoarthritis as a Chronic Pain Model
CFA inoculated rats maintained a steady weight increase
during the 9 weeks of observation, although the final
increment was 9.7% less than the control group (data not
shown). The animals appeared active generally.
Circumference of the Ankle Joint
Swelling of the injected ankles occurred in a few hours after
inoculation, and aggravated or even spread to the toes and
lower legs in 24 h. It subsided gradually after 48 h, became
limited to the ankle in a week, subsided in 3 weeks and
maintained at this level for at least 6weeks (Fig. 1A). A similar
but milder response was observed in rats inoculated with IFA.
No significant change of the diameter of the contralateral ankle
was observed.
Withdrawal Threshold to Lateral Pressure
Leg-withdrawal thresholds to lateral pressure decreased
significantly compared with the IFA-inoculated group or the
contralateral side of the same group (P < 0.01, Fig. 1B) at the
third week after CFA inoculation. The hyperalgesia main-
tained for  4 weeks, and returned to the normal level by ninth
week. No significant reduction occurred in IFA-inoculated
group (P > 0.05).
Leg-withdrawal Scores in Flexion Pain Test
Results obtained from the flexion pain tests revealed that (i) an
increase in pain scores occurred only in the ipsilateral side,
suggesting a local rather than general lesion; (ii) a similar
abrupt increase in arthritic pain appeared in both the CFA- and
IFA-inoculated groups, suggesting the development of acute
inflammation; (iii) a decrease in pain scores of the IFA group
occurred in the third week and disappeared in the fourth week,
which was in contrast to the maintenance of high levels of pain
scores for at least 9 weeks in the CFA group, suggesting the
existence of chronic hyperalgesia (Fig. 1C and D).
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A slight narrowing of the joint cavity and roughening of the
articular surface of the inoculated ankle was observed 6 weeks
after CFA inoculation (Fig. 1E and G). No significant change
of the bone density was observed around the joint at 4 and
6 weeks following the CFA injection. No X-ray changes were
seen in IFA-injected group at the same time points of
observation (data not shown).
Pathological Study
Pathological study revealed that the arthritis was localized to
the site of injection, accompanying swelling of the joint-
capsule, narrowing of the joint cavity and roughening of the
articular surfaces at 4 and 6 weeks after CFA injection (data
not shown).
Optimal Parameters of Repeated 100 Hz TENS for the
Treatment of Chronic Inflammatory Hyperalgesia
Consecutive TENS Treatments with Different Intervals
The schedule forthe treatment was once-a-week, twice-a-week
or five-times-a-week using the medium intensity stimulation
(1-2-3 mA). TENS was administered (i) beginning at 24 h after
the injection of CFA, and lasted for 3 weeks for the treatment
of acute period of arthritis; (ii) starting at fourth week and
extended to ninth week after the intra-articular injection of
CFA, for the treatment of chronic period of arthritis. The
indices measured include body weight, circumference of the
ankle and scores of arthritic flexion pain tests, which were
performed once-a-week just prior to the TENS treatment.
Acute Period of Arthritis
Repeated TENS treatments were delivered at different
intervals as follows: once-a-week (Fig. 2: 1A–D), twice-a-
week (Fig. 2: 2A–D) and five-times-a-week (Fig. 2: 3A–D) on
the acute period of monoarthritis (Weeks 1–3 after intra-
articular injection of CFA). The ankle circumference was
decreased in the group receiving twice-a-week TENS treat-
ment (Fig. 2: 2B). On the contrary, it increased in the five-
times-a-week TENS group (Fig. 2: 3B) compared with the
control group. No significant change was observed for other
indices (Fig. 2).
Chronic Period of Arthritis
The results are shown in Fig. 3. When TENS was applied in the
stable period of monoarthritis (i) the indices were improved in
rats receiving TENS once-a-week as shown by an increase in
the body weight at the time point of 5, 6, 7, 8 and 9 weeks after
injection of CFA (Duncan’s test following ANOVA, P < 0.01)
(Fig. 3: 1A), a reduction of swelling of the infected ankle
(Fig. 3: 1B, two-way ANOVA from fifth week through ninth
week), a robust decrease in the flexion pain scores at the sixth
week through ninth week (Mann–Whitney U-test, P < 0.01 for
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Figure 1. Behavioral tests and X-ray examination in rats injected intra-articularly with the Freund’s adjuvant (FA) at the right ankle joint. Ankle circumference
(A), withdrawal threshold to lateral pressure (B) and pain score evaluated by the plantar (C) or dorsal (D) flexion of the hind paw were examined (n ¼ 10 in each
group). Whole body (E) radiograph and high power view of bilateral ankles of a rat were taken at the sixth week after intra-articular injection of CFA at the right
ankle. (F) and (G) are the enlargements of the left and right ankle joint from E. Ipsi and contra represent the side of ankle joint ipsilateral or contralateral to that
receivingintra-articularinjection. IFA, incomplete Freund’sadjuvant;CFA, completeFreund’s adjuvant.*P < 0.05, **P < 0.01comparedwith the levelmeasured
before the FA inoculation (Week 0).
#P < 0.05,
##P < 0.01 compared with left ankle at the same time point.
68 TENS suppresses inflammatory pain and SP releaseall) (Fig. 3: 1C and D). (ii) Administered twice-a-week, TENS
treatment produced a moderate decrease in the plantar flexion
pain score at sixth week through eighth week after injection of
CFA (Mann–Whitney U-test, P < 0.05) (Fig. 3: 2C). The other
three indices did not change significantly (Fig. 3: 2A, B and
D). (iii) Applied five-times-a-week, there were no obvious
improvements in body weight, ankle swelling and plantar pain
test (Fig. 3: 3A, B and C). Rather, the dorsal flexion pain score
was slightly higher than mock TENS group at eighth and ninth
week after injection of CFA (Mann–Whitney U-test, P < 0.05)
(Fig. 3: 3D).
TENS Treatments with Different Intensities
The rats were inoculated intra-articularly at right ankle and
were distributed randomly into four groups as follows: three
TENS groups using three levels of intensity (low: 1-1-2 mA,
medium: 1-2-3 mA and high: 2-3-4 mA) and the control group.
TENS treatment was administered beginning at 24 h after the
injection of CFA and lasted for 9 weeks, using once-a-week or
twice-a-week schedule.
Once-a-week
The results are shown in Fig. 4. The low intensity (1-1-2 mA)
TENS treatment induced a marked and sustained decrease
in the plantar flexion pain test (Friedman ANOVA on ranks,
P < 0.01, P < 0.05, respectively). Medium intensity TENS
induced a moderate drop of scores of flexion pain test
(Friedman ANOVA on ranks, P < 0.05). It is notable that no
therapeutic effect was observed with high intensity TENS. The
growth rate of body weight and the circumference of the
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Figure 2. Multiple sessions of 100 Hz TENS with twice-a-week schedule reduce joint swelling in the acute period of rat monoarthritis induced by intra-articular
injection of CFA at the right ankle. TENS was administered with medium intensity of stimulation (1-2-3 mA), beginning at 24 h after the injection of CFA (shown
by arrows on the horizontal bar). For control group, TENS skin electrodes were placed on the same regions of skin but no current was delivered. **P < 0.01 (two-
way ANOVA between two curves from the first week to the fourth week).
eCAM 2007;(4)1 69inflamed ankle showed no significant difference between the
TENS group and the control group (data not shown).
Twice-a-week
No significant change of any indices was observed in any
TENS group (data not shown).
Suppression of Spinal Release of SP by Repeated
100 Hz TENS
Monoarthritic rats produced by intra-articular injection of CFA
at right ankle were randomly distributed into 12 groups, given
spinal perfusion at 1, 2, 3, 5, 7 and 9 weeks, respectively, after
injection of CFA. At each time point, the TENS (1-1-2 mA,
once-a-week) group was accompanied by a control (mock
TENS) group. At each time point 3–4 naı ¨ve rats were used, in
which the above-mentioned indices were measured and spinal
perfusate was collected. The results are shown in Fig. 5.
Observation of the Behavioral Indices
The TENS treatment started from the first week through ninth
week. Rats were sacrificed at different stages of the experi-
ment. The results shown in Fig. 5A–C were composed of data
obtained from different groups of rats, showing the reprodu-
cibility of the TENS efficacy.
The circumferences of the inflamed ankles of rats that
received TENS treatments were significantly lower than that
of the control group (ANOVA, P < 0.05) (Fig. 5A); the
leg-withdrawal scores of arthritic plantar and dorsal flexion
pain test were also decreased significantly (Kruskal–Wallis,
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Figure 3. Multiple 100 Hz TENS treatments given once-a-week reduce joint swelling and pain scores in the stable period of rat monoarthritis induced by intra-
articular injection of CFA at the right ankle. TENS treatments with medium intensity (1-2-3 mA) were administered from fourth week through ninth week after the
injection of CFA (shown by arrows on the horizontal bar). *P < 0.05, **P < 0.01 compared with control group at the same time point [ANOVA followed
by Duncan’s test forthe bodyweight and ankle circumferences in (A) and (B), Kruskal–Wallis ANOVA followed by Dunn’s test forthe painscores in (C) and (D)].
#P < 0.05 compared between two groups from fifth week through ninth week (two-way ANOVA).
70 TENS suppresses inflammatory pain and SP releaseP < 0.05 and P < 0.01) (Fig. 5B and C). No significant
difference of body weight was observed between the TENS
group and the control group (data not shown).
Contents of SP-ir in the Spinal Perfusate
Significant correlation of spinal SP-ir release and body weight
in naı ¨ve rats. Figure 5D shows the regression curve of the
contents of SP-ir in spinal perfusate and the body weight in 26
naı ¨ve rats. It indicates that within the range of 180–350 g body
weight, there was a reduction of the content of SP-ir in spinal
perfusate along with the increase in body weight, showing a
negative correlation between the two factors (P < 0.05).
Influences of TENS on the contents of SP-ir in spinal
perfusate. In the control (mock TENS) group, there was a
significant decrease in SP-ir content in spinal perfusate at
1 week after the injection of CFA (ANOVA followed by
Duncan’s test, P < 0.05, Fig. 5E), which returned to the level
of naı ¨ve rats at the second week and then gradually declined
with time until the ninth week after CFA injection. In the
TENS group, however, a steady gradual decrease in SP-ir
content was observed. The decrease became statistically
significant at fifth week to ninth week compared with the
control value at Week 0. In the period from second week
through ninth week, the levels of SP-ir in rats that received
TENS treatments were significantly lower than that of the
control group (two-way ANOVA, P < 0.05, Fig. 5D).
Weight-normalized contents of SP-ir in the spinal perfusate.
In order to exclude the influence of the body weight on the
contents of SP-ir, we normalized the content of SP-ir
according to the regression equation (Fig. 5D) as follows:
weight-normalized content of SP-ir ¼ actual content þ 0.2557
[body weight (g)   200], where 0.2557 is the regression
coefficient and 200 is about the average body weight at
the beginning of the experiment. The results are shown in
Fig. 5F. In the control rat, there was an abrupt decrease in
SP-ir 1 week after the injection of CFA, and then returned to
and remained approximately at the level of naı ¨ve rats. In the
TENS group, there was a mild but significant decrease in
SP-ir content, remaining there for the whole observation
period of 9 weeks. Comparison between the two curves in the
period from second week to ninth week after the injection of
CFA showed a statistically significant difference (two-way
ANOVA, P < 0.05).
Discussion
In our selection of an inflammatory pain model, we considered
various options. The adjuvant-induced polyarthritis has been
widely used for the study of chronic arthritic pain since its
introduction in 1956 by Pearson (21). However, the general
health condition in these animals could be very bad because of
the widespread immunological lesions. Thus, it brings about
many biochemical, physiological and behavioral disorders
besides pain.
Butler et al. (19) developed a monoarthritic pain model with
long-term joint hyperalgesia by injecting CFA via intra-
articular route of administration. Following Butler et al.’s
procedure using a water-in-oil type CFA, a monoarthritic
model was produced in the present study, which fulfilled the
following criteria: (i) clear manifestation of joint hyperalgesia,
(ii) hyperalgesia was maintained at a plateau for at least
6–9 weeks, (iii) minimal destruction of bone tissue and (iv) no
severe change in general health. The general condition of the
animals was quite good as shown by the steady increase in
body weight. The arthritis manifested two distinct stages.
There appeared acute redness and swelling of the joint within
hours after the articular injection, which peaked in 24 h and
subsided in the third week, whereas the joint hyperalgesia
maintained for at least six more weeks. X-ray examinations
and pathological study revealed no significant change in the
bone density around the site of injection. Thus, it appears to be
a convenient model for the study of both acute (in the first
3 weeks) and chronic (4–9 weeks after inoculation) inflam-
matory hyperalgesia.
The theoretical basis of TENS was established mainly on
the gate control concept developed by Melzack and Wall in
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Figure 4. Weak TENS treatments reduce pain scores of plantar (A) and dorsal
(B) flexion test in monoarthritic rats induced by intra-articular injection of
CFA at right ankle. 100 Hz TENS was administered once-a-week started at
24 h after injection of CFA and lasted for 9 weeks (shown by arrows on the
horizontal bar). The weak (1-1-2 mA) TENS treatment induced a decrease in
scores of flexion pain test (repeated measures ANOVA on ranks, P < 0.01).
TENS treatment with medium intensity (1-2-3 mA) induced a moderate drop
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*P < 0.05 compared with control group at the same time point (one-way
ANOVA on ranks). Note that the vertical bars are presented by median-derived
standard error, instead of MADs.
eCAM 2007;(4)1 711965 (22), which suggests that activation of large diameter
mechanoceptive fibers will presynaptically inhibit the activ-
ity of small caliber nociceptive afferents. According to this
theory, the optimal sites for placing TENS electrodes should
be chosen at the same segmental region as that of the
noxious input (23–26), and the optimal parameters for TENS
should be of low intensity and high frequency for
preferential excitation of the large diameter fibers (23).
Indeed, this has been referred to as ‘conventional TENS’ and
extensively used in clinical practice (1). In contrast to the
conventional TENS, electroacupuncture (EA) has often been
described as a peripheral conditioning stimulation of high
intensity and low frequency, which is delivered heteroseg-
mentally (27,28). However, Wang et al. (29) found no
significant difference in producing antinociception between
EA and TENS at three different levels of frequencies (2, 15
and 100 Hz). It was also found that EA and TENS exhibited
a profound cross-tolerance when the same frequency was
applied, indicating that a similar neurochemical mechanisms
may underlie both EA and TENS analgesia. The systemic
study on the specificity of acupoint in normal rats using
electrophysiological methods showed that the effect of EA
was determined by the intensity of EA stimulation, such
that weak EA produced a segmental analgesia, while strong
EA produced a generalized analgesia (30,31). TENS may
also act through modulating descending influences from
supraspinal sites (4).
Multiple studies have shown that the frequency of TENS
stimulation is an important factor for its efficacy on inflam-
matory hyperalgesia and neuropathic pain (4,32–37) and
mechanisms underlying the effects of high (>50 Hz) and low
(<10 Hz) frequency stimulation are different (1,33). We have
compared the effects of low (2 Hz) and high (100 Hz)
frequency of repeated TENS on the chronic inflammatory
hyperalgesia and found that 100 Hz TENS produced better
therapeutic effects (38).
Thus, in the present study we use high frequency (100 Hz)
TENS and placed the skin electrodes near the inflammatory
region to assure a full extent analgesic effect when different
intensities and intervals of TENS were used.
It has been generally accepted that the activation of
large diameter (Aa,A b) afferent fibers would produce a
segmental antinociceptive effects (22), whereas high intens-
ity (noxious) stimulation would also activate small diameter
(Ad, C) fibers to produce diffuse noxious inhibitory control
(DNIC) (31). In normal rats, peripheral stimulation of 1–3 mA
can produce an intensity-dependent increase in tail flick
latency, i.e. the higher the intensity, the stronger the
analgesic effect (30,31,39–41). However, Zhu et al. (42)
found that in rats with sciatic nerve injury or arthritis,
higher intensity EA did not produce a more potent analgesic
effect as compared with the low intensity stimulation. In
the present study, high intensity (2-3-4 mA) stimulation
produced little analgesic effect in contrast to the reduction
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Figure 5. Paralleled observation of the behavioral changes (top panel, A–C) and spinal SP-ir release (bottom panel, D–F). Six series of experiments were
performed in 13 groups. Behavioral indices were measured and then spinal perfusion was conducted at 1, 2, 3, 5, 7 and 9 weeks after CFA injection. One group of
naı ¨ve rats served as control. 100 Hz TENS was administered once-a-week started at 24 h after the injection of CFA. The intensity of stimulation was increased from
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received TENS treatments had a lower level of ankle swelling (A) and lower sensitivity to flexion pain tests (B and C). There was a significant decrease in SP-ir
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##P < 0.01 compared
with the mock TENS control group at the same time point (two-way ANOVA followed by Duncan’s test for ankle circumference in A, E and F; Kruskal–Wallis
ANOVA followed by Dunn’s test for the pain scores in B and C).
aP < 0.05 compared between two groups from second week to ninth week (two-way ANOVA).
72 TENS suppresses inflammatory pain and SP releaseof pain scoring in the low intensity (1-1-2 mA) group
(Fig. 4).
What then are the possible mechanisms underlying this
seemingly paradoxical phenomenon? It has been revealed that
a series of plastic changes occurred in animals with nerve
injury or tissue inflammation (43–46). In the inflammatory rat
model, there was an increase in the affinity of the opioid
receptor and an increase in the excitability of the afferent nerve
fibers not only in the spinal dorsal horn but also in many other
regions of the central nervous system (47). There was also an
increase in the spontaneous discharge of the spino-thalamic
neurons in rats with chronic sciatic nerve injury (48). One may
postulate that the signals induced by EA or TENS may be put
through more easily when there is an increase in the
excitability of the relevant nerve pathway, so that a weak
stimulation is now recognized and processed as a moderate
stimulation to produce a proper therapeutic effect, whereas a
strong stimulation would be perceived as a suprastrong stimuli
thereby exacerbate the hyperalgesia and allodynia. The
activation of large diameter primary afferents from deep
somatic tissues, not cutaneous tissues, is important in causing
TENS analgesia (49).
The effects of multiple TENS have drawn significant
attentions to the researchers (1). Among many factors, how
frequently TENS treatments need to be given for the best
outcome is less studied. In the present study we made
systemic observations on the therapeutic effects of three
different intervals of repeated 100 Hz TENS on the acute and
stable period of CFA-induced monoarthritis, and found that
for the treatment of acute period of monoarthritis (Weeks
1–3), the optimal interval is twice-a-week; while in the stable
period (Weeks 4–9), once-a-week schedule appears to
produce better therapeutic effect. When TENS was adminis-
tered too frequently (five-times-a-week), no therapeutic effect
was observed and the swelling of the inflamed ankle may
even be aggravated.
Fu et al. (50) used repeated acupuncture stimulations for the
treatment of experimental gastric ulcer in rats, and found that
every-other-day treatment was the most effective schedule for
accelerating the healing of the ulcer. Using weak EA for the
treatment of neuropathic pain in the rat it was found that once a
day or once every-other-day was most effective to suppress
hyperalgesia and allodynia (37,42,51). Wu et al. (52) used
2/100 Hz TENS for the treatment of heroin withdrawal
syndrome in drug addicts and found that in the first 2–3 days
of drug abstinence, 3–4 treatments (30 min each) a day were
needed to secure best results, which could then be reduced to
3 and then 2 treatments per day in the rest of the 2 week
detoxification period. It has also been reported that permanent
press auricular acupuncture retained in situ for 1 day after
surgery reduces the post-operative analgesic requirement after
ambulatory knee arthroscopy (53).
Taken together, the data indicate that diseases with acute
syndrome need more frequent EA or TENS treatments as
compared with chronic stage which may require more sparse
treatments for best therapeutic effect. Also this may help to
avoid developing TENS tolerance induced by frequent (daily)
treatments (54).
Involvement of SP in the TENS Treatment on
Inflammatory Hyperalgesia
To study the mechanisms of the therapeutic effect of TENS
treatment on inflammatory hyperalgesia, we focused on the
possible role played by SP in spinal cord in monoarthritic rats.
SP immunoreactivity (SP-ir) in spinal perfusate was measured
using RIA. Since the SP converting enzyme does not show an
increased activity during the period of arthritis (55,56), the
decreased level of SP-ir in spinal perfusate observed in the
present study could be taken as an index for the decreased rate
of SP release from the central nervous system, especially from
the spinal cord.
Given that the negative correlation between the content of
SP-ir in the spinal perfusate and the body weight in naı ¨ve rats,
which has also been shown in other reports (57), may serve as
the reason of the rundown of the SP-ir contents observed
during the TENS treatments, we normalized the SP-ir content
in spinal perfusate to exclude the impact of the animal growth
(body weight increase) during the observation period of more
than 2 months. An abrupt decrease in SP-ir in spinal perfusate
was observed 1 week after CFA inoculation in the control rats
without TENS, which is consistent with the findings obtained
in spinal slices (58). Also, Sluka and Westlund (12) reported
that during the acute experimental arthritis induced by
injection of kaolin and carrageenan into the knee joint there
was an initial depletion of SP contents in spinal dorsal horn,
presumably because of a massive release of SP from the
primary afferents. This may result in a depletion of SP at the
spinal dorsal horn, leading to an abrupt decrease in SP-ir in
spinal perfusate mentioned above.
It is interesting to note that this abrupt decrease in SP-ir was
not observed in the rats receiving TENS treatment. This can be
due to (i) the amelioration of inflammatory process by TENS
treatment so that the inflammation-induced increase in the
central SP release was not so dramatic as in the control group
without TENS treatment; (ii) the suppression of SP release
from the central terminal of primary afferent by the activation
of large diameter afferent fiber through gate control mechan-
ism (22). Taking the circumference of the ankle joint as an
index of the ankle swelling, namely the severity of arthritis, it
was obvious that no significant difference was found between
the groups with and without TENS at the first week, suggesting
that the inflammatory process was not significantly affected by
TENS, which is obviously not in favor of the first explanation.
Starting from the second week to the ninth week, the level of
SP-ir in the TENS group was significantly lower than the
control group, which was in parallel with the temporal course
of a significant decrease in pain scores in TENS group. This
decrease was obvious in the second week in contrast to the
significant improvement in joint swelling occurred only from
the seventh week (Fig. 5B and C). Moreover, compared with
the strong analgesic effect, the anti-inflammatory effect of
eCAM 2007;(4)1 73TENS as revealed by the reduction of joint swelling is
relatively weak. The results appear in favor of the hypothesis
thatalowintensitytranscutaneouselectricstimulation(1–2mA)
can produce a marked reduction of chronic hyperalgesia,
accompanying with a suppression of the release of SP in the
spinal cord. This is similar to the finding that single session
TENS (50 Hz, 50 V, 5 min) shows analgesic effects by
reducing the production of SP in both the dorsal root ganglion
and dorsal horn of the spinal cord (59). This may add to the
emerging evidences that some of the analgesic effects of
TENS and acupuncture may be mediated through the alteration
of neurotransmitters release, e.g. the release of aspartate,
glutamate, glycine (33,37) and nitric oxide (60) and serotoner-
gic activity (36,61,62), as well as the receptor expression, e.g.
the opioid receptor (1,33), alpha2A adrenergic receptors (63)
and muscarinic receptors (3,64).
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